ROCHESTER, NY (WROC)— Rochester Clinical Research is working to find an effective vaccine, by focusing on recruiting people of color, who are more impacted by the virus.
Adam Larrabee says Rochester Clinical Research is at the forefront of the search of a COVID-19 vaccine.
“The most important thing that we can do right now is find a vaccine for COVID-19 to help save lives,” said Adam Larrabee, president of Rochester Clinical Research, Inc.
Multiple phase 1, 2, and 3 trials are taking place at Rochester Clinical Research, and they are hoping to recruit up to 5,000 people as paid volunteers to take place in COVID-19 Vaccine Studies.
“It could be eight visits over two years, the first two visits may be within the first month and then they don’t come back for another 3-6 months and then there’s periodic phone calls,” said Larrabee.
Volunteers can make up to $150 dollars per visit. Health requirements for some of the phases are low, and researchers say they work with volunteers providing transportation and compensation for their time.
To make sure the vaccine is most effective, researchers are targeting communities of color, who are most at risk for infection.
“Those are the people that 3 times at risk of being infected and 7 times more likely to die,” said Larrabee. “We know right now that the communities of color are being infected the most. The only chance at prevention is with a vaccine.”
To learn more, you can call 585-288-0890 or visit their website here.
- DOJ accuses 6 Russian intelligence officers of vast computer hacking
- New York City Voter Guide
- Jefferson County reports 7 new COVID-19 cases Monday
- Young voters requesting ballots, but they’re returning them at a slower rate
- Newsfeed Now transforms for campaign coverage as election approaches